Bioventus (BVS) Inventory (2020 - 2026)

Bioventus (BVS) has 7 years of Inventory data on file, last reported at $83.2 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory fell 11.55% year-over-year to $83.2 million; the trailing twelve-month figure through Mar 2026 stood at $83.2 million (down 11.55% YoY), and the FY2025 full-year result was $82.2 million, down 11.07% from the prior year.
• Inventory for Q1 2026 stood at $83.2 million, up from $82.2 million in the prior quarter.
• Across five years, Inventory topped out at $97.6 million in Q3 2023 and bottomed at $64.7 million in Q2 2022.
• The 5-year median for Inventory is $90.0 million (2024), against an average of $87.5 million.
• The widest annual swing landed in 2022, when Inventory jumped 110.45%; it then retreated 11.55% in 2026.
• A 5-year view of Inventory shows it stood at $84.8 million in 2022, then climbed by 7.75% to $91.3 million in 2023, then climbed by 1.25% to $92.5 million in 2024, then fell by 11.07% to $82.2 million in 2025, then grew by 1.16% to $83.2 million in 2026.
• The last three Inventory figures came in at $83.2 million (Q1 2026), $82.2 million (Q4 2025), and $96.3 million (Q3 2025), per Business Quant data.

Peer Comparison